Lenore Sikorski, MD
MOHS-Micrographic Surgery · Laguna Niguel, CANPI 1558444083
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 262 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 22.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,338 and has fallen 58.3% since, to $558 in 2025.
Across 262 payments — averaging $22.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Merz North America, Inc.$844
- Pfizer$782
- Revance Therapeutics, Inc.$538
- Solta Medical, A Division Of Bausch Health US, LLC$424
- Biofrontera Inc.$236
- plus $2K from 26 others
What the payments were for
- Travel & lodging$150%
- Food & beverage$5,76899%
- Education$671%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 86 | $1,307 |
| Merz North America, Inc. | 13 | $844 |
| Pfizer | 43 | $782 |
| Revance Therapeutics, Inc. | 15 | $538 |
| Solta Medical, A Division Of Bausch Health US, LLC | 5 | $424 |
| Biofrontera Inc. | 13 | $236 |
| Incyte Corporation | 10 | $188 |
| Almirall LLC | 7 | $171 |
| EPI Health, LLC | 5 | $164 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 8 | $149 |
| Galderma Laboratories, L.p. | 6 | $139 |
| Arcutis Biotherapeutics, Inc. | 6 | $134 |
| VYNE Pharmaceuticals Inc. | 5 | $101 |
| Johnson & Johnson | 4 | $101 |
| UCB, Inc. | 3 | $91 |
| Mayne Pharma Commercial LLC | 6 | $56 |
| Dermira, Inc. | 2 | $52 |
| Baxter Healthcare | 2 | $48 |
| Journey Medical Corporation | 6 | $37 |
| Sanofi | 1 | $37 |
| Lilly USA, LLC | 2 | $37 |
| Dermavant Sciences, Inc. | 2 | $36 |
| Amgen | 1 | $30 |
| Organon | 3 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| LEO Pharma Inc. | 1 | $19 |
| Sandoz | 1 | $18 |
| Botanix SB Inc | 1 | $18 |
| DUSA Pharmaceuticals, Inc. | 1 | $15 |
| Sun Pharmaceutical Industries Inc. | 1 | $14 |
| Sensus Healthcare, Inc. | 1 | $11 |
| Prugen, Inc. Pharmaceuticals | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,850 in reported general payments places this provider in the 75th percentile of 144 mohs-micrographic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 38 | $1,712 |
| Tacrolimus | 19 | $1,285 |
| Fluorouracil | 19 | $1,234 |
| Imiquimod | 50 | $1,211 |
| Ketoconazole | 75 | $985 |
| Betamethasone Dipropionate | 22 | $785 |
| Doxycycline Hyclate | 64 | $714 |
| Clindamycin Phosphate | 18 | $623 |
| Triamcinolone Acetonide | 128 | $603 |
| Mupirocin | 54 | $418 |
| Hydrocortisone | 36 | $245 |
| ValacyclovirValacyclovir Hcl | 20 | $241 |
| Fluconazole | 33 | $192 |
| Terbinafine Hcl | 12 | $145 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 15 | $116 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Laguna Niguel
- Sarah ArronBurlingame$98K
- Daniel Zelacla Jolla$43K
- Ralph MasseySanta Monica$38K
- Michael MortazieOrange$29K
- Sumaira AasiStanford$27K
- Andrea WilleySacramento$21K
- Benjamin Kelleyla Jolla$20K
- Frank NoodlemanSaratoga$19K
- Howard FeinRolling Hills Estates$19K
- Joanna ChanLong Beach$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.